Initial results of the German ocular pemphigoid register

Rémi Yaïci1, Mathias Roth1, Gerd Geerling1
1Klinik für Augenheilkunde, Universitätsklinikum Düsseldorf, Düsseldorf, Deutschland

Tóm tắt

Từ khóa


Tài liệu tham khảo

Hübner F, Recke A, Zillikens D et al (2016) Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany. J Investig Dermatol 136:2495–2498. https://doi.org/10.1016/j.jid.2016.07.013

Dart JK (2017) The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on. Eye 31:301–332. https://doi.org/10.1038/eye.2016.284

Saw VPJ, Dart JKG, Rauz S et al (2008) Immunosuppressive therapy for ocular mucous membrane pemphigoid. Ophthalmology 115:253–261.e1. https://doi.org/10.1016/j.ophtha.2007.04.027

Holtsche MM, Zillikens D, Schmidt E (2018) Mucous membrane pemphigoid. Hautarzt 69:67–83. https://doi.org/10.1007/s00105-017-4089-y

Rashid H, Lamberts A, Borradori L et al (2021) European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology—Part I. J Eur Acad Dermatol Venereol 35:1750–1764. https://doi.org/10.1111/JDV.17397

Schmidt E, Rashid H, v. Marzano A et al (2021) European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology—Part II. J Eur Acad Dermatol Venereol. https://doi.org/10.1111/JDV.17395

E.Schmidt, A.Nast. AWMF-S2k-Leitlinie Diagnostik und Therapie des Schleimhautpemphigoids. AWMF-Register-Nr: 013-102, 2022 2022;

Yaïci R, Roth M, Juergens L et al (2022) Zur Versorgungssituation und konservativen Therapie des okulären vernarbenden Schleimhautpemphigoids in Deutschland. Klin Monbl Augenheilkd. https://doi.org/10.1055/a-1720-1819

Bertram F, Braecker E‑B, Zillikens D et al (2009) Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 7:434–439. https://doi.org/10.1111/j.1610-0387.2008.06976.x

Ahmed AR, Hombal SM (1986) Cicatricial pemphigoid. Int J Dermatol 25:90–96. https://doi.org/10.1111/j.1365-4362.1986.tb04544.x

Williams GP, Radford C, Nightingale P et al (2011) Evaluation of early and late presentation of patients with ocular mucous membrane pemphigoid to two major tertiary referral hospitals in the United Kingdom. Eye 25:1207–1218. https://doi.org/10.1038/eye.2011.175

Radford CF, Rauz S, Williams GP et al (2012) Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom. Eye 26:1199–1208. https://doi.org/10.1038/eye.2012.119

Kharfi M, Khaled A, Anane R et al (2010) Early onset childhood cicatricial pemphigoid: a case report and review of the literature. Pediatr Dermatol 27:119–124. https://doi.org/10.1111/j.1525-1470.2009.01079.x

Chan LS, Razzaque Ahmed A, Anhalt GJ et al (2002) The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment and prognostic indicators. Arch Dermatol 138:370–379

Thorne JE, Anhalt GJ, Jabs DA (2004) Mucous membrane pemphigoid and pseudopemphigoid. Ophthalmology 111:45–52. https://doi.org/10.1016/j.ophtha.2003.03.001

Tauber J, Melamed S, Foster CS (1989) Glaucoma in patients with ocular cicatricial pemphigoid. Ophthalmology 96:33–37

Philip AM, Fernandez-Santos CC, Ramezani K et al (2022) Ocular Mucus Membrane Pemphigoid: A Primary Versus Secondary Entity. Cornea. https://doi.org/10.1097/ICO.0000000000003056